TITLE:
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

CONDITION:
Insomnia

INTERVENTION:
MK0928, gaboxadol

SUMMARY:

      The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.
    

DETAILED DESCRIPTION:

      The duration of treatment is 1 year.
    

ELIGIBILITY:
Gender: All
Age: 65 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosis of Insomnia
      
